• Adolf Lukanović Ginekološka klinika Univerzitetni klinični center Ljubljana Šlajmerjeva 3 1000 Ljubljana
Keywords: stress urinary incontinence, adult stem cells, reconstruction of urethra, reconstruction of external urethral sphincter


Background. For one third of all women urinary incontinence is a health problem. Different strategies of treatment have been used, namely surgical, medical and physiotherapy. To this armamentarium a new method – adult stem cells therapy – has been added.

Methods. The source of adult autologues multipotent stem cells consists of muscle-derived stem cells, adipose-derived stem cells and mesenchymed bone marrow cells. In facilities for stem cells with processing and in the presence of specific inducing factors, muscle derived stem cells can be differentiated to striated or smooth muscles. Clinical work is based on animal models that with immunohistochemical analysis demonstrated new skeletal-muscle fiber formation at the site of injection of stem cells. In stress urinary incontinence (SUI) autologues bioptic material is obtained by using a musle needle biopsy device. From the biopsy speciment with dissociation muscle-derived stem cells are isolated and injected under local anaesthesia in the middle urethra and/or external urethral sphincter. Initial results of SUI treatment with adult muscle-derived stem cells suggest that perspectives of this method are encouraging.

Conclusions. Stem cell therapy is promising to become minimally invasive method for reconstruction of the muscles and connective tissue of urethra and external urethral sphincter.


Download data is not yet available.


Kerr Cl, Gerhart JD, Elliot AM, Donovan PJ. Embryonic germ

cells: when germ cells become stem cells? Semin Reprod Med

; 24: 304–13.

Pesce M, Scholer HR. Oct-4-control of totipotency and germ-lowe

determination. Mol Reprod Dev 2000; 55: 452–7.

Surani MA. Nuclear reprogramming by human embryonic stem

cells. Cell 2005; 9: 653–4.

Rosenthal N. Prometeus‘s vulture and the stem-cell promise. N

Engl J Med 2003; 17: 267–74.

Perillo A, Bonanno G, Pierelli L, Rutella S, Scambia G, Mancuso S,

et al. Stem cells in gynecology and obstetrics. Panminerva Med

; 46: 49–59.

Moise KJ. Umbilical cord stem cells. Obstet Gynecol 2005; 106:


Johnson J, Canning J, Kaneko T, Pru JK, Tiully JL. Germline stem

cells and follicular renewal in the postnatal mammalia ovary.

Nature 2004; 428: 145–50.

Bukovsky A. Can ovarian infertility be treated with bone marrow

or ovary derived germ cells? Reprod Biol Endocrinol 2005; 3:


Virant-Klun I, Zech N, Rožman P, Vogler A. Putative stem cells

with an embryonic character isolated from the ovarian surface

epithelium of women with no naturally present follicles and

oocytes. Differentiation 2008; 76: 843–56.

Taylor HS. Endometrial cells derived from donor stem cells in

bone marrow transplantant recipients. JAMA 2004; 292: 81–5.

Radley SC, Chapple CR, Bryan NP, Clarke DE, Craig DA, et al. Effects

of methoxamine on maximum urethral pressure in women

with genuine stress incontinence: a placebo-controlled, double

blind crossover study. Neurourol Urodyn 2001; 20: 43–52.

Kiilholma PJ, Chancellor MB, Markinen J, Hirsch IH, Klemi PJ, et

al. Complications of Teflon injection for stress urinary incontinence

. Neurourol Urodyn 1993; 12: 131–7.

Bent AE, Tutrone RI, Mc Lennan MT. Treatment of intrinsic

sphincter deficiency using autologous ear chondocytes as a

bulking agent. Neurourol Urodyn 2001; 20: 157–65.

Ward KL, Hiltn P. A prospective multicenter randomized trial

of tension-free vaginal top and colposuspension for primary

urodynamic stress incontinence: two year follow-up. Am J Obstet

Gynecol 2004; 190: 324–31.

Cannon TW, Lee JY, Somogyi, Pruchnic R, Smith CP, Huard J, et

al. Improved sphincter contractily after allogenic muscle-derived

progenitor cell injection into the denervated rat urethra. Urology

; 62: 958–63.

Zeng X, Jack G, Zhang R et al. Fibroblasts and adipose derived

stem cells in the treatment of stress urinary incontinence: comparison

of functional outcomes. J Urol 2007; 177: 554 (abstract


Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca

JD, et al. Multilineage potential of adult human mesenchymal

stem cells. Science 1999; 284: 143–7.

Furuta A, Carr LK, Yoshimura N, Chancellor HB. Advances in the

understanding of stress urinary incontinence and the promise

of stem-cell therapy. Rev Urol 2007; 9: 106–12.

Yokoyama T, Pruchnic R, Lee JY, Chuang YC, Jumon H, Yoshimura

N, et al. Autologous primary muscle-derived cells transfer into

the lower urinary tract. Tissue Eng 2001; 7: 395–404.

Chancellor MB, Yokohama T, Tirney S, Mattes CE, Ozawa H,

Yoshimura N, et al. Preliminary results of myoblast injection into

the urethra and bladder wall: a possible method for treatment

of stress urinary incontinence and impaired detrusor contractibility.

Neurourol Urodyn 2000; 19: 279–87.

Strasser H, Marksteiner R, Margreiter E et al. transurethral ultrasound

guided stem cell therapy of urinary incontinence. J Urol

; 175: 291.

Carr LK, Steele D, Steele S et al. Single institution clinical trial of

muscle-derived cell injection to treat stress urinary incontinence.

J Urol 2006; 175: 414.

Hijaz A, Daneshgari F, Sievert KD, Damaser MS. Animal models of

female stress urinary incontinence. J Urol 2008; 179: 2103–10.

Rodriguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ, et

al. Clonogenic multipotent stem cells in human adipose tissue

differentiate into functional smooth muscle cells . Proc Natl Acad

Sci USA 2006; 103: 12167–72.

Furuta A, Jankowski RJ, Pruchnic R, Yoshimura N, Chancellor

MB, et al. The promise of stem cell therapy to restore urethral

sphincter function. Curr Urol Rep 2007; 8: 373–8.

How to Cite
Lukanović A. STEM CELLS IN THE TREATMENT OF URINARY STRESS INCONTINENCE – A VISION OF FUTURE?. ZdravVestn [Internet]. 14Feb.2018 [cited 22Sep.2019];78. Available from: